Artal Group’s Generation Bio GBIO Stock Holding History

Artal Group’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-283,059	Closed	-$7.98M	–	38
2024 Q2	$7.98M	Hold	283,059	–	–	0.2%	47
2024 Q1	$11.5M	Buy	283,059 +1,640	+0.6%	+$38.6K	0.3%	41
2023 Q4	$4.64M	Hold	281,419	–	–	0.16%	54
2023 Q3	$10.7M	Hold	281,419	–	–	0.47%	34
2023 Q2	$15.5M	Hold	281,419	–	–	0.5%	30
2023 Q1	$12.1M	Hold	281,419	–	–	0.72%	34
2022 Q4	$11.1M	Hold	281,419	–	–	0.64%	39
2022 Q3	$14.9M	Hold	281,419	–	–	0.78%	34
2022 Q2	$18.5M	Hold	281,419	–	–	1.03%	27
2022 Q1	$20.7M	Hold	281,419	–	–	0.87%	25
2021 Q4	$19.9M	Hold	281,419	–	–	0.59%	47
2021 Q3	$70.6M	Hold	281,419	–	–	1.74%	15
2021 Q2	$75.7M	Hold	281,419	–	–	1.72%	15
2021 Q1	$80.1M	Hold	281,419	–	–	1.7%	19
2020 Q4	$79.8M	Hold	281,419	–	–	1.83%	16
2020 Q3	$87M	Hold	281,419	–	–	2.87%	10
2020 Q2	$59.1M	Buy	+281,419	New	+$62.7M	2.01%	14

Other funds holding GBIO

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return